Isatuximab as a Treatment Option for MM

Isatuximab as a Treatment Option for MM

obr

9 months
64 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Paul Richardson, MD, Clinical Program Leader, Director of Clinical Research, Jerome Lipper Multiple Myeloma, Institute Physician, Harvard Medical School considers whether isatuximab can remain a treatment option for relapsed/refractory multiple myeloma (MM).
Up Next Autoplay